IRCT20181118041689N1 IRCT 2018-11-24 Iran University of Medical Sciences The effect of melatonin and atorvastatin on diabetic nephropathy Evaluating the effect of co-administration of melatonin and atorvastatin in type II diabetic patients with microalbuminuria 2020-01-21 anticipated 120 Complete https://irct.ir/trial/35292 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The random number table and block randomization method will be used using http://www.randomizer.org.In this method, eligible patients are divided into blocks of 4 patients. We create random numbers using computer.Based on the determined numerical range to enter individuals in each group, half of the patients in each block will receive atorvastatin (20 mg) and placebo and half of them receive atorvastatin (20 mg) and Melatonin (3 mg), Blinding description: Participants, the person who puts the medication in cans and labels on the cans, the person who selects and enrols the eligible patients, A person who blocks patients and determines the allocation of medications to patients, the doctor who gives the medications to the patients, data collection authorities, those who evaluate the outcome and those who prepare the draft article do not know what kind of drugs are in each can. 3 Type 2 diabetes mellitus with kidney complication. Intervention 1: Control group: Patients with type II diabetes who have microalbuminuria and receive atorvastatin (20 mg) and placebo once a day for 6 months. Intervention 2: Intervention group: Patients with type II diabetes who have microalbuminuria and receive at the same time atorvastatin (20 mg) and Melatonin (3 mg) once a day for 6 months. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no more information.